Skip to content
Products & Services · Net Sales

Neuro Cranial Instruments — Net Sales

Stryker Neuro Cranial Instruments — Net Sales decreased by 89.9% to $606M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 89.7%, from $5.87B to $606M. Over 3 years (FY 2021 to FY 2024), Neuro Cranial Instruments — Net Sales shows an upward trend with a 9.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 11, 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates growing demand for neurosurgical equipment and successful market adoption of new cranial surgical technologies, while a decrease may signal increased competition or a slowdown in elective neurosurgical procedure volumes.

Detailed definition

This metric represents the total revenue generated from the sale of specialized surgical instruments and devices used in...

Peer comparison

Peers in the medical device sector report similar revenue streams under neurosurgery or specialized surgical instrument segments, often benchmarked against total surgical procedure volume trends.

Metric ID: syk_segment_neuro_cranial_instruments_net_sales

Historical Data

22 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q1 '26
Value$4.29B$4.16B$4.7B$4.28B$4.49B$4.48B$5.2B$4.78B$5B$4.91B$5.82B$5.24B$5.42B$5.49B$6.44B$5.87B$563M$6.02B$6.06B$7.17B$6.02B$606M
QoQ Change-3.1%+13.0%-9.1%+5.1%-0.3%+16.1%-8.2%+4.6%-1.7%+18.5%-9.8%+3.4%+1.3%+17.1%-8.9%-90.4%+969.6%+0.6%+18.4%-16.1%-89.9%
YoY Change+4.6%+7.7%+10.7%+11.8%+11.2%+9.6%+11.8%+9.7%+8.5%+11.9%+10.7%+11.9%-89.3%+11.1%+10.2%+11.4%+2.6%-89.7%
Range$563M$7.17B
CAGR-31.1%
Avg YoY Growth-1.3%
Median YoY Growth+10.5%
Current Streak2 quarters decline

Frequently Asked Questions

What is Stryker's neuro cranial instruments — net sales?
Stryker (SYK) reported neuro cranial instruments — net sales of $606M in Q1 2026.
How has Stryker's neuro cranial instruments — net sales changed year-over-year?
Stryker's neuro cranial instruments — net sales decreased by 89.7% year-over-year, from $5.87B to $606M.
What is the long-term trend for Stryker's neuro cranial instruments — net sales?
Over 3 years (2021 to 2024), Stryker's neuro cranial instruments — net sales has grown at a 9.7% compound annual growth rate (CAGR), from $17.11B to $22.6B.
What does neuro cranial instruments — net sales mean?
Total revenue generated from the sale of surgical instruments used in neurosurgical and cranial procedures.